Literature DB >> 11214903

Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism.

S Seixas1, O Garcia, M J Trovoada, M T Santos, A Amorim, J Rocha.   

Abstract

The levels of haplotype diversity associated with different alpha1-antitrypsin (PI) alleles were assessed by the analysis of three microsatellites located within or close to corticosteroid-binding globulin (CBG), alpha1-antitrypsin [PI-(TG)n] and protein C inhibitor [PCI-(TG)n] loci in three populations with different historic backgrounds: Portugal, the Basque Country and São Tomé Príncipe (Gulf of Guinea). Unlike the more distant PCI-(TG)n repeat, allelic variation at PI-(TG)n reflected distinct phases of mutational recovery of microsatellite diversity around different founder alleles and showed a considerable differentiation between alpha1-antitrypsin protein variants. In accordance with population history, the Basque sample presented overall reduced levels of microsatellite variation. The African sample, although presenting the highest PCI-(TG)n diversity, showed a lineage-specific reduction in PI-(TG)n heterozygosity within the oldest M1Ala213 variant that could have been caused by (1) selection at a closely linked locus or (2) biases in the microsatellite mutation process leading to a stable equilibrium distribution. Age estimates of alpha1-antitrypsin variants based on microsatellite variation suggest that the Z deficiency allele appeared 107-135 generations ago and could have been spread in Neolithic times. The S mutation has an older 279- to 470-generation age, indicating that its high frequencies in Iberia did not result from a recent bottleneck and that PI*S could have originated in this region. M2 and M3 types had lower age estimates than would be expected from their wide geographical distributions, suggesting that their dispersion in Europe might have been preceded by important bottlenecks.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11214903     DOI: 10.1007/s004390000434

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

1.  Microsatellite variation and evolution of human lactase persistence.

Authors:  Margarida Coelho; Donata Luiselli; Giorgio Bertorelle; Ana Isabel Lopes; Susana Seixas; Giovanni Destro-Bisol; Jorge Rocha
Journal:  Hum Genet       Date:  2005-06-01       Impact factor: 4.132

2.  Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease.

Authors:  Katie M Stiles; Dolan Sondhi; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Ronald G Crystal
Journal:  Chronic Obstr Pulm Dis       Date:  2018-08-17

Review 3.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08

Review 4.  Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.

Authors:  M Luisetti; N Seersholm
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

5.  The prevalence of alpha-1 antitrypsin deficiency in Ireland.

Authors:  Tomás P Carroll; Catherine A O'Connor; Olwen Floyd; Joseph McPartlin; Dermot P Kelleher; Geraldine O'Brien; Borislav D Dimitrov; Valerie B Morris; Clifford C Taggart; Noel G McElvaney
Journal:  Respir Res       Date:  2011-07-13

6.  How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?

Authors:  Ilaria Ferrarotti; Beata Poplawska-Wisniewska; Maria Teresa Trevisan; Janine Koepke; Marc Dresel; Rembert Koczulla; Stefania Ottaviani; Raffaele Baldo; Marina Gorrini; Giorgia Sala; Luana Cavallon; Tobias Welte; Joanna Chorostowska-Wynimko; Maurizio Luisetti; Sabina Janciauskiene
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

7.  Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years.

Authors:  Talita Stessuk; Milton Artur Ruiz; Oswaldo Tadeu Greco; Aldemir Bilaqui; Maria José de Oliveira Ribeiro-Paes; João Tadeu Ribeiro-Paes
Journal:  Rev Bras Hematol Hemoter       Date:  2013

8.  Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency.

Authors:  Caitriona McLean; Catherine M Greene; Noel G McElvaney
Journal:  Biologics       Date:  2009-07-13

Review 9.  Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed.

Authors:  Frederick J de Serres
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

10.  A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and height.

Authors:  Teri-Louise North; Yoav Ben-Shlomo; Cyrus Cooper; Ian J Deary; John Gallacher; Mika Kivimaki; Meena Kumari; Richard M Martin; Alison Pattie; Avan Aihie Sayer; John M Starr; Andrew Wong; Diana Kuh; Santiago Rodriguez; Ian N M Day
Journal:  J Med Genet       Date:  2016-02-01       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.